VRK3 Antibodies

Santa Cruz Biotechnology provides a broad selection of VRK3 monoclonal antibodies for research focused on understanding VRK3 protein functions. The monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VRK3, or Vaccinia-related kinase 3, is a serine/threonine kinase that plays a crucial role in cell cycle regulation and DNA damage response. VRK3 actively participates in various cellular processes, including cell proliferation, apoptosis, and transcriptional regulation. Research has shown that VRK3 expression levels can vary significantly across different tissue types and developmental stages. Understanding VRK3 function is essential for elucidating its implications in cancer biology and other diseases. Ongoing studies continue to reveal new insights about VRK3's role in cellular signaling pathways and its potential as a therapeutic target. Recent findings have highlighted VRK3's involvement in specific cancer types and its potential significance in disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of VRK3's role in human health and disease.